Max Power Profile
Max Power

@MaxPowerNGS

Followers
397
Following
7K
Media
287
Statuses
3K

Joined February 2014
Don't wanna be here? Send us removal request.
@MaxPowerNGS
Max Power
3 months
Everything pointing to this being not just a Fabry deal for $SGMO but much l, much more. Wouldn’t be surprised if both HemoA and Fabry go to the same partner. Maybe even open deal for future GTs using the same AAV+Promoter. Beaucoup bucks coming our way.
@Soeren_Berlin
Sören Creutzburg
3 months
$SGMO message from Sandy 🚀 Thanks Wizard
1
2
18
@MaxPowerNGS
Max Power
2 months
Bullish. That’s just what prospective partners want to hear.
@BiotechAnalysst
Phoenix Biotech
2 months
$SGMO In October, held a meeting with #FDA to discuss the proposed efficacy and safety data package where, in the meeting minutes, among other things, the FDA #reiterated its October 2024 agreement to use eGFR slope as an endpoint to support an #accelerated #approval pathway👍
1
0
8
@BiotechAnalysst
Phoenix Biotech
2 months
$SGMO In October, held a meeting with #FDA to discuss the proposed efficacy and safety data package where, in the meeting minutes, among other things, the FDA #reiterated its October 2024 agreement to use eGFR slope as an endpoint to support an #accelerated #approval pathway👍
4
3
23
@MaxPowerNGS
Max Power
2 months
3) potential of Fabry is keeping bidders at the table SM is trying to extract max value for the entire $SGMO gene therapy pipeline engine. Lots of potential targets (e.g. PKU, others) that are available and could work with proven vector and strong promoter.
0
0
4
@MaxPowerNGS
Max Power
2 months
My theory for the past couple months is the following: 1) multiple bidders for Fabry based on exceptional data 2) SM trying to bundle package of Fabry+HemoA+other GT targets, but this is less appealing based on HemoA durability questions. GT is no longer core to $SGMO
@mehtamanal
Manal Mehta
2 months
I just wish someone who has kicked the tires on $SGMO #Fabry data would come out and say: here’s why it isn’t interesting. I can accept defeat on trial failure. But the company’s representations vs the inability to close a deal is truly mind boggling. @sandymacrae23 why nothing?
1
1
5
@MaxPowerNGS
Max Power
2 months
I expect Sandy to get out in front of this question about FDA temperature on Fabry early approval. Hopefully we can trust his view on an increasingly mercurial agency.
@Soeren_Berlin
Sören Creutzburg
2 months
@GothamGirl_1 @Franca_ole @meangenebio I personally wouldn’t say “don’t worry,” because concern is fair — what’s troubling here isn’t Sangamo’s data, it’s the FDA’s inconsistency. Slowing down a first-in-class gene therapy for a fatal disease is frustrating, but it doesn’t directly translate to Fabry. 1) The FDA
0
0
1
@MaxPowerNGS
Max Power
2 months
The $NTLA soap opera keeps delivering. Perfect way to pass the time before football starts.
1
0
3
@MaxPowerNGS
Max Power
2 months
$SGMO early morning earnings call means they are announcing a deal before the market opens. Load the boat!!
@BiotechAnalysst
Phoenix Biotech
2 months
$SGMO november 6 , 8:30 #AM
1
0
12
@MaxPowerNGS
Max Power
2 months
How is this even possible? 12 weeks! $SGMO
@BiotechAnalysst
Phoenix Biotech
2 months
BOOOM: HUGE $SGMO Pain trial update: Its now a #Phase2 Data not 52 but 12 !!! weeks https://t.co/soNMk3Xcnd
3
1
15
@MaxPowerNGS
Max Power
2 months
$SGMO must be getting really creative in finding ways to keep the lights on. Where is the deal Sandy!
2
0
10
@MaxPowerNGS
Max Power
2 months
Waiting for Sandy’s announcement. $sgmo
1
0
13
@MaxPowerNGS
Max Power
2 months
$SGMO shorts about to experience their own Pain Trial now that $SGMO has the funding they need.
@BiotechAnalysst
Phoenix Biotech
2 months
BREAKING $SGMO Pain trial just #started recruiting (means they #got the #funding to go on) https://t.co/jLINdDtjXs now we wait for the big PR ....
5
3
39
@MaxPowerNGS
Max Power
2 months
$SGMO I got a feeling Sandy is going to have a big announcement this week. Combined with a TACO Monday will be a fun week!
1
0
16
@MaxPowerNGS
Max Power
2 months
Jain will be executing those $8.77 options soon enough…
@809trader
809 trader
3 months
$SGMO new form 3
0
0
0
@MaxPowerNGS
Max Power
3 months
$SGMO
@Soeren_Berlin
Sören Creutzburg
3 months
$SGMO — think we’re in the endgame now. ‘Soon’ is coming and I am looking forward to it. I’m aware of at least three different people (including myself) who regularly exchange with Sangamo IR (Louise) or Sandy — all sent messages between last Thursday and Monday, and none have
2
0
18
@BiotechAnalysst
Phoenix Biotech
3 months
$SGMO #Tregs - STEADFAST study marks a true breakthrough - Outstanding safety profile - Very promising early efficacy signals - immunosuppression tapering was achieved This pioneering approach has the potential to redefine transplantation management... #nobelprice
0
3
31
@MaxPowerNGS
Max Power
3 months
That’s a huge buy signal on $QURE. @CramerTracker
@BiotechAnalysst
Phoenix Biotech
3 months
$QURE CC @CramerTracker
1
1
26
@MaxPowerNGS
Max Power
3 months
Wow…there’s a lot of $SGMO Bullish Pennant bots spamming today…
0
0
11
@MaxPowerNGS
Max Power
3 months
$SGMO going green to finish the week strong!
1
0
5
@MaxPowerNGS
Max Power
3 months
Someone enroll Legette in $SGMO Prion clinical trial!!! 😱
@MLFootball
MLFootball
3 months
🚨🚨THIS IS INSANE🚨🚨 #Panthers wide receiver Xavier Legette taking a squirrel out the tree and RIPPED IT’S SKIN OFF. “Took the clothes off him.” XL then cooks the squirrels and eats them for dinner. One of the craziest things to eat 😭😭
2
0
4
@MaxPowerNGS
Max Power
3 months
We can forget about a Fabry deal for $SGMO.... this company is getting acquired very soon!
@jawnzilla
J🅰️wn Z🧬lla
3 months
$SGMO 8K is quite odd to me: https://t.co/STsINVMjzp I am no expert, but some thoughts below via ChatGPT prompting. Key thing to me: why the need to so explicitly call out severance benefits accruing to the outgoing CFO in the event of 'Change of Control' while keeping her
3
2
18